Sjövall Johanna, Bitzén Ulrika, Kjellén Elisabeth, Nilsson Per, Wahlberg Peter, Brun Eva
Department of Otorhinolaryngology (ORL)-Head and Neck Surgery, Skane University Hospital, Lund University, 22185, Lund, Sweden.
Department of Clinical Physiology and Nuclear Medicine, Skane University Hospital, Lund University, Lund, Sweden.
Eur J Nucl Med Mol Imaging. 2016 Apr;43(4):609-16. doi: 10.1007/s00259-015-3194-3. Epub 2015 Oct 2.
The aim of this study was to determine whether PET scans after radiotherapy (RT), visually interpreted as equivocal regarding metabolic neck node response can be used to accurately categorize patients as responders or nonresponders using a Likert scale and/or maximum standardized uptake value (SUVmax). Other aims were to determine the performance of different methods for assessing post-RT PET scans (visual inspection, a Likert scale and SUVmax) and to establish whether any method is superior in predicting regional control (RC) and overall survival (OS).
In 105 patients with neck node-positive head and neck cancer, the neck node response was evaluated by FDG PET/CT 6 weeks after RT. The scans were clinically assessed by visual inspection and, for the purposes of this analysis, re-evaluated using the Deauville criteria, a five-point Likert scale previously used in lymphoma studies. In addition, SUVmax was determined.
All assessment methods were able to significantly predict RC but not OS. The methods were also able to significantly predict remission of tumour after completion of RT. Of the 105 PET scans, 19 were judged as equivocal on visual inspection. The Likert scale was preferable to SUVmax for grouping patients as responders or nonresponders.
All methods (visual inspection, SUVmax and the Likert scale) identified responders and nonresponders and predicted RC. A Likert scale is a promising tool to reduce to a minimum the problem of PET scans judged as equivocal. Consensus regarding qualitative assessment would facilitate PET reporting in clinical practice.
本研究的目的是确定放疗(RT)后进行的PET扫描,在视觉上对颈部淋巴结代谢反应判断不明确时,是否可使用李克特量表和/或最大标准化摄取值(SUVmax)准确地将患者分类为反应者或无反应者。其他目的是确定评估放疗后PET扫描的不同方法(视觉检查、李克特量表和SUVmax)的性能,并确定是否有任何方法在预测区域控制(RC)和总生存期(OS)方面更具优势。
对105例颈部淋巴结阳性的头颈癌患者,在放疗后6周通过FDG PET/CT评估颈部淋巴结反应。扫描结果通过视觉检查进行临床评估,并且为了本分析的目的,使用多维尔标准重新评估,这是先前在淋巴瘤研究中使用的五点李克特量表。此外,还测定了SUVmax。
所有评估方法均能显著预测区域控制,但不能预测总生存期。这些方法也能够显著预测放疗完成后肿瘤的缓解情况。在105例PET扫描中,19例在视觉检查中被判定为不明确。在将患者分组为反应者或无反应者方面,李克特量表比SUVmax更可取。
所有方法(视觉检查、SUVmax和李克特量表)均能识别反应者和无反应者并预测区域控制。李克特量表是一种很有前景的工具,可将被判定为不明确的PET扫描问题降至最低。关于定性评估的共识将有助于临床实践中的PET报告。